NCT03986424 - Local Study of Akatinol Memantine in VaD in Russia | Biotech Hunter

Enrollment

130

Participants

Timeline

Start Date

January 23, 2018

Primary Completion Date

June 1, 2022

Study Completion Date

June 1, 2022

Conditions

Vascular Dementia

Interventions

DRUG

Akatinol Memantine 20 mg

Akatinol Memantine 20 mg to be taken orally, once daily, in the same time of the day

DRUG

Akatinol Memantine 10 mg

Akatinol Memantine 10 mg to be taken orally, twice daily

Trial Locations (4)

115522

"Federal State Budgetary Scientific Institution Mental Health Research Center", Moscow

117198

"Federal State Autonomous Institution of Higher Learning Peoples' Friendship University of Russia, Medical Institute", Moscow

125367

Scientific Research Institute of Neurology, Merz Investigational Site #0070008, Moscow

194044

"Federal state budgetary military educational institution of higher education Military Medical Academy named after S.M. Kirov of the Ministry of defence of the Russian Federation", Saint Petersburg